The Recall Desk

Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Filters

Agency

Category

Minimum severity

Clear filters

17526–17550 of 18009

  • ModerateFDA (Drugs)·D-145-2013·2013-02-13

    Watson Pharmaceuticals Recalls Taztia XT Due to Dissolution Failure

    Watson Pharmaceuticals is recalling Taztia XT (diltiazem HCI) capsules because stability testing revealed a failed dissolution specification.

    Product
    Taztia XT(diltiazem HCI extended release capsules, USP, Once-A-Day Dosage, 360 mg, 90 Capsules per bottle, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880, Distributed by: Watson Pharma, NDC 62037-700-90.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-149-2013·2013-02-13

    West-ward Recalls Prednisone Tablets Due to Gray Defects

    West-ward Pharmaceutical Corp. is recalling specific lots of PredniSONE Tablets, USP, 10 mg, due to the presence of gray defects in the tablets.

    Product
    PredniSONE Tablets, USP, 10 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1473-01), b) 1000-count tablets per bottle (NDC 0143-1473-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatowntown, NJ 07724.
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-156-2013·2013-02-13

    Bayer Recalls Leukine Sargramostim Vials Due to Impurities

    Bayer HealthCare Pharmaceuticals is recalling Leukine sargramostim vials because a confirmed out-of-specification result for impurities was found in one lot.

    Product
    Leukine sargramostim 5 x 500 mcg/mL vial, liquid injection, Sterile Rx only, Mfd by: Bayer HealthCare Pharmaceuticals, LLC Seattle, WA 98101 U.S. Lic. No. 1791 NDC 58468-0181-2
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-152-2013·2013-02-13

    Sandoz Recalls Syeda Oral Contraceptives for Incorrect Tablet Imprinting

    Sandoz is recalling Syeda oral contraceptives because some tablets have the wrong ID imprint. Consumers should stop using the affected lot and contact a healthcare provider.

    Product
    Syeda (drospirenone and ethinyl estradiol), 3 mg/0.03 mg, 3 x 28 tablet blistercards, combination oral contraceptive tablet, Manufactured by Laboratorios Leon Farma S.A., Spain for Sandoz Inc., Princeton, NJ
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-144-2013·2013-02-13

    Stat Rx USA Recalls Methocarbamol Tablets Due to Incorrect Expiration Date

    Stat Rx USA is recalling 3 bottles of Methocarbamol 750 mg tablets distributed in Pennsylvania because they were labeled with an incorrect expiration date.

    Product
    Methocarbamol 750 mg Tablets, 90-count bottle, Mfg by: West-Ward Pharm. Corp., Eatontown, NJ 07724, Packaged and Distributed by: Stat Rx USA, NDC 42549-521-90.
    Category
    Drug
    Distribution
    1 state
  • LowFDA (Drugs)·D-146-2013·2013-02-13

    Ascend Recalls EstroGel Pump Defect

    Ascend Therapeutics is recalling 4,835 bottles of EstroGel (estradiol gel) 0.06% because the pump head may detach from the canister.

    Product
    EstroGel (estradiol gel) 0.06%, contained in 50-gr metered pumps, 1.25g/pump depression, for use as physician starter samples; product is labeled in part ***Manufactured for ASCEND Therapeutics Herndon, VA 20170 by DPT Laboratories San Antonio TX 78215***
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-151-2013·2013-02-13

    Estee Lauder DayWear Moisturizer Recalled for Potential Sunscreen Instability

    Estee Lauder is recalling DayWear Sheer Tint Release moisturizer because the sunscreen ingredient may be unstable, potentially reducing its effectiveness.

    Product
    ESTEE LAUDER DayWear Sheer Tint Release, Advanced Multi-Protection Anti-Oxidant Moisturizer Broad Spectrum SPF15, All Skin types, 1.7 FL. OZ. LIQ/50 ml (tube inside a unit carton) with UPC No. 2713179904, Code WKEM-01, and 1.5 mL foil sample packets, ESTEE LAUDER, DIST., NEW…
    Category
    Consumer Product
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-138-2013·2013-02-06

    Qualitest Recalls Hydrocodone and Acetaminophen Tablets Due to Oversized Size

    Qualitest Pharmaceuticals is recalling 897,379 bottles of Hydrocodone bitartrate and acetaminophen tablets because a complaint reported the tablets were oversized.

    Product
    Hydrocodone bitartrate and acetaminophen Tablets, USP, 10 mg/500 mg, packaged in a) 30-count bottles, NDC 0603-3888-16; b) 60-count bottles, NDC 0603-3888-20; c) 90-count bottles, NDC 0603-3888-02; d) 100-count bottles, NDC 0603-3888-21; e) 120-count bottles, NDC 0603-3888-22…
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-140-2013·2013-02-06

    Hillyard Hand Sanitizer Recalled for Potential Bacterial Contamination

    Hillyard GMP is recalling specific lots of Alcohol Free Foaming Instant Hand Sanitizer due to potential bacterial contamination.

    Product
    HILLYARD ALCOHOL FREE FOAMING INSTANT HAND SANITIZER — HILLYARD ALCOHOL FREE FOAMING INSTANT HAND SANITIZER (BENZALKONIUM CHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-137-2013·2013-02-06

    Mylan Recalls Carvedilol Tablets for Weight and Thickness Failures

    Mylan Pharmaceuticals is recalling 11,580 bottles of Carvedilol 12.5 mg tablets because they failed specifications for weight and thickness.

    Product
    Carvedilol Tablets, USP, 12.5 mg, 500-count tablets per bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC 0378-3633-05, UPC 3 0378-3633-05 3.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-141-12013·2013-02-06

    Femtrace Tablets Recalled for Moisture Ingress and Impurity Failures

    Warner Chilcott is recalling 5,439 bottles of Femtrace 0.9 mg tablets nationwide due to moisture ingress causing failed impurity specifications.

    Product
    Femtrace 0.9 mg (Estradiol Acetate) Tablets, Rx Only, 100 tablets, Manufactured by Pharmaceutics International Inc, Hunt Valley, MD 21031 for Warner Chilcott Company LLC, Fajardo, PR 00738
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-139-2013·2013-02-06

    Schering-Plough Recalls Temodar Capsules Due to Degradation Testing Failures

    Schering-Plough is recalling 17,169 packages of Temodar (temozolomide) 20 mg capsules due to out-of-specification degradation product testing results.

    Product
    Temodar (temozolomide) Capsule, 20 mg per capsule, 5 capsules per package, For Oral Administration, Rx Only, Cytotoxic, NDC: 0085-1519-02, Schering Corporation, Kenilworth, New Jersey, 07033
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-142-2013·2013-02-06

    Femtrace 0.45 mg Tablets Recalled for Moisture Ingress

    Warner Chilcott is recalling 3,155 bottles of Femtrace 0.45 mg tablets due to moisture ingress that failed impurity specifications.

    Product
    Femtrace 0.45 mg (Estradiol Acetate) Tablets, Rx Only, 100 tablets, Manufactured by Pharmaceutics International Inc, Hunt Valley, MD 21031 for Warner Chilcott Company LLC, Fajardo, PR 00738
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-135-2013·2013-01-30

    Genentech Recalls Trastuzumab Kits Due to Potential Glass Particulates

    Genentech is recalling 2,140 Trastuzumab Kits for investigational use because the included Bacteriostatic Water for Injection diluent vials may contain glass particulates.

    Product
    Trastuzumab Kit containing 1 vial Trastuzumab (nominal content: 440 mg); 1 20 mL multiple dose vial Bacteriostatic Water for Injection, USP (1.1% benzyl alcohol), Manufactured by Hospira, Inc., for Genentech, Inc., South San Francisco, CA 94080-4990, NDC 50242-903-69; and 1…
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-131-2013·2013-01-30

    West-ward Recalls Propylthiouracil Tablets Due to Foreign Substance Presence

    West-ward Pharmaceutical Corp. is recalling specific lots of Propylthiouracil Tablets, USP, 50 mg because uncharacteristic spots identified as steel corrosion, degraded tablet material, and hydrocarbon oil were found.

    Product
    Propylthiouracil Tablets, USP, 50 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1480-01) and b) 1000-count tablets per bottle (NDC 0143-1480-10), Rx only, Manufactured by: West-ward Pharmaceuticals Corp. Eatontown, NJ 07724.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-130-2013·2013-01-30

    West-ward Recalls Lisinopril Tablets Due to Foreign Substance Presence

    West-ward Pharmaceutical Corp. is recalling specific lots of Lisinopril Tablets, USP 40 mg, because uncharacteristic black spots were found in the tablets.

    Product
    Lisinopril Tablets, USP 40 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1270-01); b) 1000-count tablets per bottle (NDC 0143-1270-10); Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ 07724; and c) 1000-count tablets per bottle (NDC…
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-132-2013·2013-01-30

    West-ward Recalls Lisinopril and Hydrochlorothiazide Tablets Due to Foreign Particulates

    West-ward Pharmaceutical Corp. is recalling specific lots of Lisinopril and Hydrochlorothiazide Tablets because they contain minute stainless steel particulates.

    Product
    Lisinopril and Hydrochlorothiazide Tablets, 20 mg/25 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1264-01) and b) 1000-count tablets per bottle (NDC 0143-1264-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ 07724.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-133-2013·2013-01-30

    West-ward Recalls Prednisone Tablets Due to Foreign Substance Presence

    West-ward Pharmaceutical Corp. is recalling PredniSONE Tablets, USP, 20 mg, due to the presence of foreign substances including stainless steel inclusions.

    Product
    PredniSONE Tablets, USP, 20 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1477-01), b) 500-count tablets per bottle (NDC 0143-1477-05), and c) 1000-count tablets per bottle (NDC 0143-1477-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatowntown, NJ…
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-136-2013·2013-01-30

    Flanax Antacid Recalled for Missing Tamper-Evident Cap Band

    Belmora LLC is recalling 17,996 bottles of Flanax antacid because the caps lack a tamper-evident breakaway band.

    Product
    Flanax (aluminum hydroxide, magnesium hydroxide, and simethicone) Fast Acting Antacid, 200 mg/200 mg/20 mg, 12 fl oz (355 mL) bottles, Distributed by: Belmora LLC, PO Box 3063, Arlington, VA 22203, UPC 8 53030 00209 0, NDC 27854.101.01.
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-134-2013·2013-01-30

    Major Oral Peroxide Recalled Due to Stability Data Concerns

    Axcentria Pharmaceuticals is recalling Major Oral Peroxide because stability data indicates the product degrades below acceptable levels before the printed expiration date.

    Product
    Major Oral Peroxide (Carbamide Peroxide 10%), 2 fl oz (60 mL), Distributed by: Major Pharmaceuticals 31778 Enterprise Drive, Livonia, MI 48150, NDC 0904-4062-03
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-125-2013·2013-01-23

    Perrigo Recalls Prednisone Tablets Due to Foreign Substance Contamination

    L. Perrigo Co. is recalling specific lots of 10mg Prednisone tablets contaminated with trace food-grade lubricant and stainless steel inclusions.

    Product
    Prednisone tablets, USP, 10mg, Rx Only, Units of Use, NDC: a) 45802-303-67, 48-count Cartons, b) 45802-303-21, 21-count Cartons, Manufactured by: West-Ward Pharmaceutical Corporation, Eastown, NJ 07724, Distributed by: Perrigo, Allegan, MI 49040.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-126-2013·2013-01-23

    Boehringer Ingelheim Recalls Perindopril Erbumine Tablets Due to Impurity

    Boehringer Ingelheim Roxane Inc. is recalling 3,553 bottles of Perindopril Erbumine Tablets, 8mg, because out-of-specification results were found for impurity B.

    Product
    Perindopril Erbumine Tablets, 8mg, 100 Tablets per Bottle, Rx Only, Boehringer Ingelheim, Roxane Laboratories Inc., Columbus, OH 43216, NDC 0054-0112-25.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-129-2013·2013-01-23

    James G. Cole Recalls I-C Drops Eye Cleansing Agent for Sterility Labeling

    James G. Cole, Inc. is recalling I-C Drops Eye Cleansing Agent because the label does not state the product is sterile, as required by FDA regulations.

    Product
    I-C Drops, Eye Cleansing Agent, 15 ml ASN/Maxam P.O. Box 1277 Hood River, OR 97031
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-127-2013·2013-01-23

    Upsher Smith Recalls Divalproex Sodium Tablets Due to Labeling Error

    Upsher Smith is recalling 11,316 bottles of Divalproex Sodium Delayed-Release Tablets because some labels are missing the color-coded strength indicator.

    Product
    Divalproex Sodium Delayed-Release Tablets, USP, 500 mg Valproic Acid Activity, 100-count tablets per bottle, Rx only, Manufactured by Upsher-Smith Laboratories, Inc., Minneapolis, MN 55447, NDC 0245-0182-11.
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-128-2013·2013-01-23

    Teva Recalls Cabergoline Tablets Due to Impurity Specification Failure

    Teva Pharmaceuticals is recalling 13,232 bottles of Cabergoline 0.5 mg tablets because the product may not meet impurity specifications over its shelf life.

    Product
    CABERGOLINE — CABERGOLINE (CABERGOLINE)
    Category
    Drug
    Distribution
    Distributed nationwide